EUVIMEDEUVIMED entdecken
Open Access

Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children

A Kwara, H Yang, C Martyn-Dickens, A Enimil, A K Amissah, O Ojewale, A Dompreh, D Bosomtwe, E Sly-Moore, T Opoku, A F Appiah, R Obeng und 5 weitere

The International Journal of Tuberculosis and Lung Disease · 01.05.2023 · 27 (5) · 401-407

DOI: 10.5588/ijtld.22.0591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 01.05.2023. Verfasst von A Kwara und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA, Medical Service, North Florida South Georgia Veterans Health…. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We examined whether the updated WHO weight-band dosing recommendations and fixed-dose combination tablets for the treatment of TB in children achieves recommended calculated dosages and adequate drug plasma exposure. DESIGN/METHODS: Children on first-line TB treatment per WHO guidelines were enrolled. Blood sampling at pre-dose, 1, 2, 4, 8, and 12 h post-dose after at least 4 weeks of treatment was performed. Drugs concentrations were measured using validated liquid chromatography tandem with mass spectrometry and pharmacokinetic parameters calculated using noncompartmental analysis. Plasma drug exposure below the lower limit of the 95% confidence interval of the mean for children was considered low and above the upper limit was high. RESULTS: Of 71 participants, 34 (47.9%) had HIV coinfection. The median calculated dose for isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and ethambutol (EMB) was 10.0 (range 4.3–13.3), 15.0 (range 8.6–20.0), 30.0 (range 21.0–40.0), and 20.4 (range 14.3–26.7) mg/kg, respectively. Overall, most patients had under-exposure for RIF and PZA and over-exposure for INH and EMB. Drug dose and weight-for-age Z -score were associated with area under the curve from time 0–24 h for all drugs. CONCLUSIONS: Despite adherence to WHO dosing guidelines, low PZA and RIF plasma exposures were frequent in our study population. Higher than currently recommended dosages of RIF and PZA may be needed in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsTuberculosisHumansChildIsoniazidRifampinPyrazinamideEthambutolWorld Health Organization

Substanzen

Antitubercular AgentsIsoniazidRifampinPyrazinamideEthambutol

Autor:innen und Institutionen

  • Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA, Medical Service, North Florida South Georgia Veterans Health System, Gainesville, FL, USA.
  • Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Directorate of Child Health, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana.
  • Directorate of Child Health, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana, Department of Child Health, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
  • Department of Clinical Microbiology, KATH, Kumasi, Ghana, Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Kwara, A., Yang, H., Martyn-Dickens, C., Enimil, A., Amissah, A. K., Ojewale, O., Dompreh, A., Bosomtwe, D., Sly-Moore, E., Opoku, T., Appiah, A. F., Obeng, R., Asiedu, P., Maranchick, N., Alshaer, M. H., Peloquin, C. A., & Antwi, S. (2023). Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children. The International Journal of Tuberculosis and Lung Disease, 27(5), 401-407. https://doi.org/10.5588/ijtld.22.0591

Vancouver

Kwara A, Yang H, Martyn-Dickens C, Enimil A, Amissah AK, Ojewale O, et al. Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children. The International Journal of Tuberculosis and Lung Disease. 2023;27(5):401-407. doi:10.5588/ijtld.22.0591

BibTeX
@article{Kwara2023,
  author = {Kwara, A and Yang, H and Martyn-Dickens, C and Enimil, A and Amissah, A K and Ojewale, O and Dompreh, A and Bosomtwe, D and Sly-Moore, E and Opoku, T and Appiah, A F and Obeng, R and Asiedu, P and Maranchick, N and Alshaer, M H and Peloquin, C A and Antwi, S},
  title = {Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2023},
  volume = {27},
  number = {5},
  pages = {401--407},
  doi = {10.5588/ijtld.22.0591}
}
Kostenlos starten →